Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 201

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders

Open access
Sacco, Kristi A., Bannon, Katie L., George, Tony P. · 2004 · Journal of Psychopharmacology

Abstract

Cigarette smoking rates in the American population are approximately 23%, whereas rates of smoking in clinical and population studies of individuals with neuropsychiatric disorders are typically two- to four-fold higher. Studies conducted in a variety of neuropsychiatric populations [e.g. attention-deficit hyperactivity disorder (ADHD), Alzheimer’s disease, schizophrenia] have collectively suggested that nicotine may be efficacious in remediating selected cognitive deficits associated with these disorders, thus providing a framework for understanding the specific vulnerability of these patients to smoking initiation and maintenance. However, the specific gain in cognitive performance produced by nicotine administration in healthy subjects with normal cognitive function is less clear. This article reviews our current understanding of central nicotinic acetylcholine receptor (nAChRs) systems in normal and neuropsychiatric disease states and, specifically, their role with respect to cognitive dysfunction and clinical symptoms in several specific neuropsychiatric populations, including ADHD, Alzheimer’s disease, Parkinson’s disease, Tourette’s Disorder, schizophrenia and affective disorders. The potential benefits of nicotinic agents for therapeutic use in neuropsychiatric disorders is discussed, as well as directions for further research in this area.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881104047273

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 169

  1. 10.1177/01454455960204001 · DOI
  2. 10.1176/ajp.150.12.1856 · DOI · Paper page
  3. 10.2165/00002512-199711060-00004 · DOI
  4. 10.1038/sj.npp.1300265 · DOI
  5. 10.1016/S0166-2236(00)01716-1 · DOI · Paper page
  6. 10.1016/0091-3057(85)90139-X · DOI · Paper page
  7. 10.1212/WNL.30.8.839 · DOI
  8. 10.1080/02791072.1999.10471731 · DOI
  9. Beckham J C, 1995, Addict Behav, 20, 1, 10.1016/0306-4603(94)00037-Y · DOI
  10. 10.1002/jts.2490080308 · DOI
  11. 10.1016/S0306-4603(96)00071-8 · DOI · Paper page
  12. 10.1016/0304-3940(92)90179-B · DOI
  13. 10.1007/978-3-7091-0643-3_11 · DOI
  14. Breese C R, 1997, J Pharmacol Exp Ther, 282, 7
  15. 10.1016/S0893-133X(00)00121-4 · DOI · Paper page
  16. 10.1212/WNL.43.2.293 · DOI · Paper page
  17. 10.1001/archpsyc.56.12.1141 · DOI · Paper page
  18. 10.1016/S1353-8020(03)00028-2 · DOI
  19. 10.1007/BF02245195 · DOI
  20. Conners C K, 1995, The Continuous Performance Test
  21. Conners C K, 1996, Psychopharmacol Bull, 32, 67
  22. 10.1192/bjp.179.1.35 · DOI
  23. 10.1016/S0006-3223(00)01116-1 · DOI · Paper page
  24. 10.1016/S0006-3223(00)01101-X · DOI · Paper page
  25. 10.1176/ajp.155.11.1490 · DOI · Paper page
  26. 10.1080/14622200210141635 · DOI
  27. Delagarza V W, 2003, Am Family Phys, 68, 1365
  28. 10.1007/s002130050631 · DOI
  29. 10.1177/026988119901300106 · DOI
  30. 10.1016/S0893-133X(02)00372-X · DOI · Paper page
  31. Donnelly Roberts D L, 1998, J Pharmacol Exp Ther, 285, 777
  32. 10.1007/s002130100719 · DOI
  33. 10.1017/S0033291796003984 · DOI
  34. 10.1124/mol.64.6.1283 · DOI
  35. 10.1002/1531-8257(199911)14:6<1011::AID-MDS1016>3.0.CO;2-F · doi:10.1002/1531-8257(199911)14:6<1011::aid-mds1016>3.0.co;2-f
  36. 10.1007/BF02806011 · doi:10.1007/bf02806011
  37. 10.1016/S0091-3057(02)00711-6 · DOI
  38. 10.1016/S0893-133X(01)00257-3 · DOI · Paper page
  39. 10.1073/pnas.061369098 · DOI · Paper page
  40. 10.1007/BF02244882 · DOI
  41. First M, 1994, Diagnostic and statistical manual of mental disorders
  42. 10.1007/BF02805972 · DOI · Paper page
  43. 10.1038/379733a0 · DOI · Paper page
  44. 10.1073/pnas.93.24.14065 · DOI · Paper page
  45. 10.1016/S0166-4328(00)00206-0 · DOI · Paper page
  46. 10.1046/j.1471-4159.1999.0721117.x · DOI
  47. Fryer J D, 1999, J Pharmacol Exp Ther, 288, 88
  48. 10.1016/0091-3057(95)02063-2 · DOI
  49. 10.1016/j.tips.2003.11.003 · DOI · Paper page
  50. George T P, 2001, Psychiatr Times, 18, 39
  51. 10.1016/S0006-8993(98)00537-X · DOI
  52. George T P, 2000, J Pharmacol Exp Ther, 295, 58
  53. 10.1016/S0893-133X(01)00296-2 · DOI · Paper page
  54. George T P, 2003, American College of Neuropsychopharmacology
  55. George T P, 2003, Medical illness in schizophrenia
  56. 10.1007/s002130050554 · DOI
  57. 10.1093/bmb/65.1.21 · DOI
  58. 10.1016/S0006-3223(99)00130-4 · DOI · Paper page
  59. 10.4088/JCP.v59n0503 · DOI
  60. 10.1212/WNL.52.1.115 · DOI · Paper page
  61. 10.1093/oxfordjournals.aje.a116960 · DOI · Paper page
  62. 10.1176/ajp.154.6.799 · DOI · Paper page
  63. 10.1007/BF02251289 · DOI · Paper page
  64. 10.1007/s00213-002-1005-6 · DOI · Paper page
  65. 10.1046/j.1471-4159.1996.67051953.x · DOI · Paper page
  66. 10.1016/S0899-3289(20)30005-5 · DOI
  67. 10.1080/14622299050011971 · DOI
  68. 10.1007/s002130000541 · DOI
  69. 10.1007/s002130050493 · DOI
  70. 10.1017/S1041610201007888 · DOI
  71. 10.1007/s002130000399 · DOI
  72. 10.1146/annurev.pu.10.050189.000555 · DOI
  73. 10.1007/BF02247426 · DOI · Paper page
  74. Kelton M C, 2000, Brain Cognit, 43, 274
  75. 10.1016/S0306-4603(01)00266-0 · DOI
  76. 10.1016/S0091-3057(99)00006-4 · DOI
  77. 10.1159/000054957 · DOI
  78. 10.1007/s002130050109 · DOI
  79. 10.1007/s002130050800 · DOI
  80. 10.1007/s002130050360 · DOI
  81. 10.1001/jama.284.20.2606 · DOI · Paper page
  82. 10.1016/S0896-6273(02)01004-8 · DOI · Paper page
  83. 10.1007/BF02244994 · DOI
  84. 10.1080/14622200110050213 · DOI · Paper page
  85. 10.1001/archpsyc.59.12.1085 · DOI · Paper page
  86. 10.1007/BF02247415 · DOI · Paper page
  87. 10.1007/s002130050667 · DOI · Paper page
  88. 10.1007/BF02246285 · DOI
  89. 10.1016/S0893-133X(96)00018-8 · DOI · Paper page
  90. 10.1007/s002130050750 · DOI · Paper page
  91. 10.1016/S0926-6410(98)00044-5 · DOI
  92. 10.1037/1064-1297.9.1.83 · doi:10.1037/1064-1297.9.1.83 · Paper page
  93. Lezak M D, 1995, Neuropsychological assessment
  94. 10.1007/s002130051107 · DOI
  95. 10.1002/neu.10148 · DOI · Paper page
  96. McConville B J, 1991, Am J Psychiatry, 148, 793, 10.1176/ajp.148.6.793 · DOI
  97. 10.1016/0006-3223(92)90315-Q · DOI
  98. 10.1007/s002130100899 · DOI
  99. 10.1016/S0028-3932(98)00012-8 · DOI
  100. 10.1007/BF02247425 · DOI
  101. 10.1038/npp.1994.11 · DOI
  102. 10.2165/00002512-199711030-00005 · DOI · Paper page
  103. 10.1007/BF00174504 · DOI · Paper page
  104. 10.1080/14622299050011371 · DOI
  105. 10.1038/sj.npp.1300173 · DOI
  106. 10.1016/S0893-133X(97)00095-X · DOI
  107. 10.1016/S0165-1781(03)00022-2 · DOI
  108. 10.1016/S0893-133X(99)00098-6 · DOI
  109. 10.1124/mol.54.6.1132 · DOI · Paper page
  110. 10.3109/15622970309167951 · DOI
  111. 10.1159/000118807 · DOI
  112. 10.1007/s004150050299 · DOI · Paper page
  113. 10.1080/1462220021000018425 · DOI · Paper page
  114. Perkins K A, 1994, J Pharmacol Exp Ther, 270, 628
  115. 10.1007/BF00445565 · DOI
  116. Picciotto M R, 2003, Trends Pharmacol Sci, 23, 494
  117. 10.1007/s002130050722 · DOI
  118. 10.1016/0306-4603(94)90058-2 · DOI
  119. 10.1300/J069v20n01_07 · DOI
  120. 10.1016/0899-3289(95)90030-6 · DOI · Paper page
  121. 10.1046/j.1360-0443.2002.00117.x · DOI
  122. 10.1007/BF02245662 · DOI
  123. 10.1017/S0317167100046321 · DOI
  124. 10.1212/WNL.37.2.226 · DOI
  125. 10.1523/JNEUROSCI.22-21-09604.2002 · DOI
  126. 10.1007/s002210000407 · DOI · Paper page
  127. 10.1002/ana.410190502 · DOI · Paper page
  128. 10.1016/S0014-2999(02)01452-8 · DOI
  129. 10.1097/00008877-200011000-00009 · DOI · Paper page
  130. Sacco K A, 2004, Nicotinic recepter mechanisms and neuropsychological functioning in schizophrenia: effects on spatial working memory and attention
  131. 10.1192/bjp.154.6.797 · DOI · Paper page
  132. 10.1002/hup.424 · DOI
  133. Salin-Pascual R J, 1996, J Clin Psychiatry, 57, 387
  134. 10.1124/jpet.102.045773 · DOI · Paper page
  135. 10.1124/jpet.103.051912 · DOI
  136. 10.1016/S0006-3223(02)01342-2 · DOI
  137. 10.1007/BF02247722 · DOI
  138. 10.3109/15622970209150616 · DOI
  139. 10.1097/00004583-200109000-00020 · DOI · Paper page
  140. Simon R, 2002, Clinical neurology
  141. 10.1016/S0893-133X(02)00324-X · DOI · Paper page
  142. Snaedal J J T, 1996, Dementia, 7, 47
  143. 10.1016/0376-8716(89)90090-2 · DOI
  144. 10.1177/070674370200601S13 · DOI
  145. 10.1111/j.1360-0443.1994.tb00869.x · DOI
  146. 10.1007/BF02316865 · DOI
  147. 10.1176/ajp.155.8.1009 · DOI · Paper page
  148. 10.1007/s002130050573 · DOI · Paper page
  149. 10.1016/S0014-2999(99)00886-9 · DOI
  150. Suter T W, 1983, Activas Nervosa Superior, 25, 261
  151. 10.1177/026988119200600210 · DOI · Paper page
  152. 10.1016/S0278-5846(01)00194-4 · DOI
  153. 10.1176/appi.ajp.157.3.368 · DOI · Paper page
  154. 10.1080/10673220127912 · DOI · Paper page
  155. Vezina P, 1992, JPET, 261, 484
  156. Victor M, 2001, Adams and Victor’s principles of neurology
  157. 10.1212/WNL.57.6.1032 · DOI
  158. 10.1159/000109692 · DOI
  159. 10.1016/0091-3057(91)90109-F · DOI
  160. 10.1037/0894-4105.14.3.409 · DOI · Paper page
  161. Weiss M, 2003, adults. Can Med Assoc J, 168, 715
  162. 10.1007/BF00432014 · DOI
  163. 10.1007/s002130000382 · DOI · Paper page
  164. 10.1007/BF00432045 · DOI
  165. 10.1007/s002130050931 · DOI · Paper page
  166. 10.1016/0091-3057(95)00043-V · DOI · Paper page
  167. Yang Y K, 2002, Neuropsychpharmacology, 27, 684
  168. 10.1124/jpet.103.048777 · DOI
  169. 10.1177/1073858402239588 · DOI

Cited by

See all 201

Metadata

Authors
Sacco, K. A., Bannon, K. L., & George, T. P.
Venue
Journal of Psychopharmacology
Published
2004-12
Volume
18
Issue
4
Pages
457-474
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W4319292982
Cited by
201
References
28
FWCI
6.34
Type
journal article
Language
en
Open access
green
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.